Skip to content

Effects of aerobic training with cumin supplementation on serum ß-endorphin levels and pain intensity

The effect of an aerobic training course with and without cumin supplementation on serum ß-endorphin levels and pain intensity in non-athlete girls with primary dysmenorrhea

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140519017756N41
Enrollment
26
Registered
2018-03-23
Start date
2017-05-05
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group (Cumin): cumin capsules (300 milligrams every 8 hours) on the first 3 days plus 28 days of aerobic exercise from the fourth day. Intervention 2: Control group (place

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: age 18 to 25 years Moderate to severe dysmenorrhea (pain intensity score from 4 to 10) Single girl Non-athlete Regular monthly cycles of more than 21 days and less than 35 days Pain during menstruation

Exclusion criteria

Exclusion criteria: Consumption of hormonal medications and any type of herbal or chemical tranquilizers affecting menstrual bleeding since 48 hours before menstruation to the end of the research project Cardiovascular, hepatic and renal disease Genital tract infection Pelvic damage Secondary dysmenorrhea

Design outcomes

Primary

MeasureTime frame
Serum levels of beta-endorphin. Timepoint: on the third days of the first and next menstruation cycles. Method of measurement: ELISA kit (EASTBIOPHARM Company).;Pain intensity. Timepoint: on the third days of the first and next menstruations. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohadese Eidy Kakhky

Birjand University of Medical Sciences

M.eidykakhky1993@gmail.com+98 56 3239 5680

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026